The Evaluation of Serum Biomarkers for Non-small Cell Lung Cancer (NSCLC) Diagnosis-Reference-Cited by-同舟云学术

The Evaluation of Serum Biomarkers for Non-small Cell Lung Cancer (NSCLC) Diagnosis

Published:2018-11-29 Issue: Volume:9 Page:
ISSN:1664-042X
Container-title:Frontiers in Physiology
language:
Short-container-title:Front. Physiol.

Author:

Fang Rui,Zhu Yong,Khadka Vedbar S.,Zhang Fan,Jiang Bin,Deng Youping

Funder

Foundation for the National Institutes of Health

Publisher

Frontiers Media SA

Subject

Physiology (medical),Physiology

Reference25 articles.

1. A multiplexed serum biomarker immunoassay panel discriminates clinical lung cancer patients from high-risk individuals found to be cancer-free by CT screening.;Bigbee;J. Thorac. Oncol.,2012

2. Prolactin as a potential early predictive factor in metastatic non-small cell lung cancer patients treated with nivolumab.;Caponnetto;Oncology,2017

3. Serum tumor markers CEA, CYFRA21-1, and CA-125 are associated with worse prognosis in advanced non-small-cell lung cancer (NSCLC).;Cedres;Clin. Lung Cancer,2011

4. Utility of serum cytokeratin 19 fragment (CYFRA 21-1) and carcinoembryonic antigen (CEA) as tumour markers for non-small cell lung cancer.;Chantapet;J. Med. Assoc. Thai.,2000

5. Potentially useful biomarkers for the diagnosis, treatment and prognosis of lung cancer.;Cho;Biomed. Pharmacother.,2007

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum-Based Biomarker Panels are Crucial Tools for the Early Detection of Lung Cancer in High-Risk Individuals in North Indian Population;Indian Journal of Clinical Biochemistry;2024-09-14

2. Diagnostic potential of protein serum biomarkers for distinguishing small and non-small cell lung cancer in patients with suspicious lung lesions;Biomarkers;2024-06-18

3. The causal association between serum metabolites and lung cancer based on multivariate Mendelian randomization;Medicine;2024-02-16

4. MECOM: a Bioinformatics and Experimentally Identified Marker for the Diagnosis and Prognosis of Lung Adenocarcinoma;Biomarkers in Medicine;2024-01

5. Association of CA19-9 with Prognosis of Non-Small Cell Lung Cancer;Advances in Clinical Medicine;2024